Evidence map›Paper›PMID 19452348›Full record

ArticleScandinavian journal of infectious diseases2009

Risk factors for death after sepsis in patients immunosuppressed before the onset of sepsis.

Debra D Poutsiaka, Lisa E Davidson, Katherine L Kahn, David W Bates, David R Snydman, Patricia L Hibberd

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Scandinavian journal of infectious diseases, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03617965 (Mortality Due to Septic Shock Associated With Thrombocytopenia in the Intensive Care Unit), which is not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03617965 unknown statusnot on this mapstarted 2018, after this paper: background citation

Mortality Due to Septic Shock Associated With Thrombocytopenia in the Intensive Care Unit

TypeobservationalSponsorUniversidad de GuanajuatoRan2018 to 2019Enrolled350ConditionsThrombocytopenia, Septic Shock, Sepsis BacterialArmsPlatelet count
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 53 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Staphylococcus aureus bacteremia in immunosuppressed patients: a multicenter, retrospective cohort study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017
    Article
  17. Article
  18. Progression from severe sepsis in pregnancy to death: a UK population-based case-control analysis.BJOG : an international journal of obstetrics and gynaecology · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Debra D PoutsiakaDivision of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts Medical Center, Boston, Massachusetts 02111, USA. dpoutsiaka@tuftsmedicalcenter.org
Lisa E Davidson
Katherine L Kahn
David W Bates
David R Snydman
Patricia L Hibberd
Tufts Medical Center · USBrigham and Women's Hospital · USLos Angeles Medical Center · US

Funding

TUFTS CLINICAL AND TRANSLATION SCIENCE INSTITUTE (UL1): BPCAUL1RR025752 · NCRR · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2008 to 2011
$17.6M
Midcareer Investigator Award in Patient-Oriented Research (K24)K24AT003683 · NCCIH · TUFTS MEDICAL CENTER · PI HIBBERD, PATRICIA L · 2006 to 2015
$1.9M
Clinical Research Training in Infectious DiseasesT32AI055412 · NIAID · TUFTS MEDICAL CENTER · PI SNYDMAN, DAVID RICHARD · 2005 to 2014
$1.3M
MENTORED PATIENT-ORIENTED RESEARCH CAREEER DEVELOPMENT AWARDK23RR020042 · NCRR · TUFTS MEDICAL CENTER · PI POUTSIAKA, DEBRA D · 2005 to 2009
$738k
Tufts Clinical and Translational Science Institute (K12)KL2RR025751 · NCRR · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2008 to 2011
$596k
NCCIH NIH HHS K24 AT003683NCRR NIH HHS K23 RR020042NCRR NIH HHS KL2 RR025751NCRR NIH HHS UL1 RR025752NIAID NIH HHS T32 AI055412
6 · The paper itself

Abstract

Few studies have focused on sepsis in patients with pre-existing immunosuppression. Since the numbers and the incidence of sepsis are increasing, sepsis in immunosuppressed patients will increase in importance. We studied the epidemiology of sepsis and risk factors for 28-d mortality in patients immunosuppressed prior to the onset of sepsis using data from the Academic Medical Center Consortium's (AMCC) prospective observational cohort study of sepsis. We compared characteristics of immunosuppressed (n =412) and immunocompetent (n =754) patients. Immunosuppressed patients were younger and more likely to have underlying liver or lung disease, and nosocomial infection or bloodstream infection of unknown source when presenting with sepsis. They were also more likely to die within 28 d compared to immunocompetent patients (adjusted relative risk 1.62, 95% CI 1.38 - 1.91). Septic shock, hypothermia, cancer and invasive fungal infections were associated with increased mortality in immunosuppressed patients. Black race and the presence of rigors were independent predictors of survival in immunosuppressed patients. We conclude that sepsis among patients immunosuppressed prior to the onset of sepsis was associated with higher mortality than in immunocompetent patients. As the numbers of immunosuppressed patients continue to grow, more studies on the epidemiology of sepsis in this group will become increasingly important.

Indexed as

AgedAge FactorsAnalysis of VarianceChi-Square DistributionFemaleHumansImmunocompromised HostKaplan-Meier EstimateLogistic ModelsMaleMiddle AgedRisk FactorsSepsis

Identifiers

PMID19452348
PMCPMC4129637
OpenAlexW2007483610

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.